Unknown

Dataset Information

0

CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.


ABSTRACT: The dysregulation of epidermal growth factor receptor (EGFR) signaling has been well documented to contribute to the progression of non-small cell lung cancer (NSCLC), the leading cause of cancer death in the world. EGF-stimulated EGFR activation induces receptor internalization and degradation, which plays an important role in EGFR signaling. This process is frequently deregulated in cancer cells, leading to enhanced EGFR levels and signaling. Our previous study on CMTM7 is only limited to a brief description of the relationship of overexpressed CMTM7 with EGFR-AKT signaling. The biological functions of endogenous CMTM7 and its molecular mechanism remained unclear. In this study, we show that the stable knockdown of CMTM7 augments the malignant potential of NSCLC cells and enhances EGFR-AKT signaling by decreasing EGFR internalization and degradation. Mechanistically, CMTM7 knockdown reduces the activation of Rab5, a protein known to be required for early endosome fusion. In NSCLC, the loss of CMTM7 would therefore serve to sustain aberrant EGFR-mediated oncogenic signaling. Together, our findings highlight the role of CMTM7 in the regulation of EGFR signaling in tumor cells, revealing CMTM7 as a novel molecule related to Rab5 activation.

SUBMITTER: Liu B 

PROVIDER: S-EPMC4747392 | biostudies-other | 2015 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.

Liu Baocai B   Su Yu Y   Li Ting T   Yuan Wanqiong W   Mo Xiaoning X   Li Henan H   He Qihua Q   Ma Dalong D   Han Wenling W  

Oncotarget 20151201 38


The dysregulation of epidermal growth factor receptor (EGFR) signaling has been well documented to contribute to the progression of non-small cell lung cancer (NSCLC), the leading cause of cancer death in the world. EGF-stimulated EGFR activation induces receptor internalization and degradation, which plays an important role in EGFR signaling. This process is frequently deregulated in cancer cells, leading to enhanced EGFR levels and signaling. Our previous study on CMTM7 is only limited to a br  ...[more]

Similar Datasets

| S-EPMC7828377 | biostudies-literature
| S-EPMC8099477 | biostudies-literature
| S-EPMC5589578 | biostudies-literature
| S-EPMC3318742 | biostudies-literature
2024-02-20 | GSE225198 | GEO
| S-EPMC6497573 | biostudies-literature
| S-EPMC6642601 | biostudies-literature
| S-EPMC7276200 | biostudies-literature
| S-EPMC8561617 | biostudies-literature
| S-EPMC3497614 | biostudies-literature